About: Jason Novak

mm

Website:
Bio: Jason has been a consistent contributor to VectorVest and has a blended interest in technology and finance, which he has written about for over a decade. When he's not demystifying complex financial topics or sharing a quick analysis of hot stocks on a given day, you may find him on the golf course or exploring all that Northern California has to offer.

Posts by Jason Novak:

Eli Lilly Climbs 8% on Impressive Earnings and Upbeat Outlook as Drug Sales Surge: Time to Buy?

Posted on: 08 Aug 2024

CVS Falls After Disappointing Earnings as Healthcare-Benefits Struggle: Time to Sell?

Posted on: 07 Aug 2024

How to Trade Nasdaq Stocks or Indices

Posted on: 07 Aug 2024

There are so many different stocks you can invest in as you begin building a stock portfolio – VectorVest tracks more than 16,000 of them! Yet, those listed on the Nasdaq are among the most exciting opportunities. These represent the highest-performance companies from the tech sector along with businesses from healthcare, consumer goods & services, […]

Palantir Jumps 11% on Strong Q2 Earnings Fueled By AI Demand: Why It’s Not Quite Time to Buy PLTR

Posted on: 06 Aug 2024

Amazon’s Earnings and AI Stance Have Analysts Excited, But VectorVest Says to SELL AMZN Today

Posted on: 05 Aug 2024

Exxon Inches Further Away From Competitors in Q2, But it May Not Be Time to Buy XOM Yet

Posted on: 02 Aug 2024

Meta’s Q2 Results and Outlook Send Shares Higher: 3 Other Reasons It’s Time to Buy This Stock

Posted on: 01 Aug 2024

AMD Climbs 5% After Beating Expectations in Q2, Sharing Optimistic Outlook: Time to Buy AMD?

Posted on: 31 Jul 2024

JetBlue Posts Unexpected Profit That Has Shares Climbing 18% Higher: Is it Time to Buy JBLU?

Posted on: 30 Jul 2024

Heineken Drops 10% After Profit Miss: 3 Other Reasons it May Be Time to SELL HEINY

Posted on: 29 Jul 2024